PPD Opens Its Largest Europe Center in Bulgaria's Sofia
US company Pharmaceutical Product Development (PPD), Inc., has announced the opening of a pharmacovigilance and medical communications center in Sofia, Bulgaria.
The center will deliver PPD’s full range of drug safety, medical information and medical writing services to meet growing client demand, the company announced as cited by Business Wire.
The Sofia facility of PPD will offer medical information call center support, adverse event capture, safety case processing and reporting, and periodic report writing services from Bulgaria
Sofia will become the company’s largest safety center and its third European hub for medical communications contact center services. PPD opened its Athlone, Ireland, facility in March and also operates contact center services in Stockholm, Sweden.
This infrastructure gives PPD the capability to provide biopharmaceutical companies with global and regional support for pre- and post-approval drug safety and medical information, the company points out.
The PPD statement emphasizes the fact that with multiple medical and pharmacy schools in the area, Sofia offers a large pool of highly trained health care professionals with extensive language capabilities.
PPD has already hired more than 20 employees at its Sofia center with plans to expand to more than 200 professionals in the next 12 months.
These will include physicians, pharmacists, nurses and medical specialists who provide safety and medical information support services, including product inquiries, adverse event and product complaint intake, case processing and reporting of drug safety concerns.
“Expanding our safety and medical communications operations in Europe strengthens our ability to bring high quality global health care expertise to provide these services in an efficient, cost-effective and regulatory compliant manner. There is strong demand for both pre- and post–approval safety services, and we have an experienced management team on the ground in Bulgaria to oversee our operations and to create customized programs that meet client needs,” said Christine Dingivan, M.D., chief medical officer of PPD as cited by Business Wire.
“PPD is a leader in its field and has decided to make a significant investment in Bulgaria with its plan to create more than 200 positions in this important technical field. Bulgaria has a noteworthy and rich history of innovation and technology, and both PPD and the people of Bulgaria can benefit from this venture. The U.S. Embassy looks forward to further strengthening our relationship with PPD as it expands in this region,“ stated U.S. Ambassador to Bulgaria, James Warlick, who attended the opening event in Sofia on Tuesday.
PPD is a global contract research organization providing drug discovery, development and lifecycle management services for 25 years. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. The company has offices in 41 countries and more than 10 500 employees worldwide.
- » Bulgaria's Gross Foreign Debt Decrease by EUR 200 M at Beginning of 2017
- » Serbia's PM: Bulgaria Is Scared By Serbia's Progress
- » Europe's Largest Banks Declare 26% of Profits in Tax Havens
- » Number of Tourists Visiting Pamporovo Increases with Over 30%
- » Chief of Road Infrastructure Agency Resigns
- » BNB: Deposits Increased By Over 7% in February